Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients

BACKGROUND: β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES: We aimed to investigate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordbar, Mohammad Reza, Silavizadeh, Samir, Haghpanah, Sezaneh, Kamfiroozi, Roza, Bardestani, Marzieh, Karimi, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102988/
https://www.ncbi.nlm.nih.gov/pubmed/25068055
http://dx.doi.org/10.5812/ircmj.18028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102988/
https://www.ncbi.nlm.nih.gov/pubmed/25068055
http://dx.doi.org/10.5812/ircmj.18028

Ejemplares similares